Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Politics
Health
4-FA
4-FMP
designer drug
nightlife
XTC
Ecstasy
pills
powder capsule
opium law
hard drugs
Martin van Rijn
Klaas Dijkhoff
Daan van der Gouwe
Trimbos
Jellinek
Wednesday, 24 May 2017 - 18:55

Share this article:

Popular designer drug 4-FA banned

Popular designer drug 4-Fluoroamphetamine, also known as 4-FA and 4-FMP, will be banned in the Netherlands beginning Thursday. The party drug will be on the classified as "List I" under the country's drug laws, meaning it will be labeled as a hard drug.

Both the Trimbos institute and addiction facility Jellinek, organizations typically present at large Dutch festivals to assist drug users, alerted the government last September about the rising health incidents involving 4-FA. At the time, they cautioned the drug produced symptoms including headaches, heart problems and strokes. They previously voiced their criticism of 4-FA’s public image as ‘XTC-light’, arguing the drug is much less innocent than it is believed to be by many party goers.

This decision to ban the drug was made by the State Secretary for Public Health, Welfare and Sport, Martin van Rijn, and Klaas Dijkhoff, Secretary of Security and Justice. The drug had already been banned in Germany and the United Kingdom.

Multiple people have been admitted to the hospital after using the designer drug, the Volkskrant reported. In all cases the drug had been combined with other drugs or alcohol, or had been used in excess.

This is one main risk of 4-FA’s relatively milder effect – users run the risk of underestimating the impact of the drug, which is available for a few euros per pill or powder capsule. Last year more 4-FA pills were admitted to Dutch drug testing points than in all previous years combined.

It is questionable whether the ban will actually have an effect on usage however. Despite being banned in 1988, ecstasy, or XTC, remains popular in Dutch nightlife. Ecstasy pills have also increased in strength in recent years with producers of the drug manufacturing them in secret.

Trimbos researcher Daan van der Gouwe previously told the Volkskrant that banning the drug would not be a solution in any case. “It won’t make any difference in terms of use. If you ban it, it will disappear into the underground scene. From the perspective of monitoring it might make sense to just keep an eye on it, without immediately banning it.”

More like this

Image
Ecstasy pills
Utrecht dance festival accused of promoting drug use in social media post
Image
A woman makes a line of the designer drug, 3-Methylmethcathinone, better known as 3-MMC, on a mirror. October 2021
Young adults in Amsterdam increasingly turn to designer drugs and gambling
Image
A small bag with several grams of the designer drug, 3-Methylmethcathinone, better known as 3-MMC, alongside a euro note used to snort a line off a mirror. October 2021
More people in the Netherlands using designer drug 3-MMC on nights out
Image
Telegram
Some 2.5 million Telegram ads for drugs in Netherlands last year
Make NL Times your top Google source

Follow us:

Latest stories

  • Cheaper summer public transport deal to launch earlier in June than planned
  • Record 38 players from Dutch clubs set for expanded World Cup
  • Wasteful Oranje punished as Algeria snatch late victory in World Cup warm-up
  • Dutch State buys medieval ring found with metal detector for €83,150
  • Rotterdam shooting suspect arrested in Spain within days of fleeing

Top stories

  • Court rules Ye can remain in Netherlands for Arnhem performances this week
  • New A'dam coalition planning parking +tourist tax hike, free public transport for kids
  • European Commission tells Netherlands to stop extra border controls
  • Pregnant woman thrown to ground at Zeist asylum shelter was trying to ask cop a question
  • Senior Dutch virologist, colleague accused of smuggling inactive Mpox into United States

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content